期刊文献+

年龄和环境对肾细胞癌临床病理特征的影响 被引量:1

Effects of Age and Circumstance on Clinicopathologic Features of Renal Cell Carcinoma
下载PDF
导出
摘要 目的探讨不同年龄和生活环境的肾细胞癌的临床病理特征。方法回顾性分析256例肾细胞癌患者的年龄、临床症状、临床分期、淋巴结转移、远处转移、病理特征等方面资料,比较<40岁组、40~60岁组和>60岁组间及农村和城市间的临床及病理特征。结果①在肾细胞癌中透明细胞癌的所占比例随年龄增长而增加,三组间两两比较差异有统计学意义(P=0.01);嫌色细胞癌和集合管癌的所占比例则随年龄增长逐渐减少,三组间两两比较差异有统计学意义(P=0.047);肾细胞癌病理类型与环境无关。②40~60岁组中无症状肾细胞癌所占比例均高于<40岁组与>60岁组,且与<40岁组比较有显著性差异(P=0.02);Ⅲ期肾细胞癌在40~60岁组中的比例明显低于<40岁组(P=0.04)和>60岁组(P=0.059),且前者差异有统计学意义;农村肾细胞癌患者中Ⅰ期肾癌比例低于城市组(P=0.0001),而Ⅲ期肾细胞癌(P=0.0007)和Ⅳ期肾细胞癌(P<0.0001)比例显著高于城市。③40~60岁组肾细胞癌患者淋巴结转移比例低于<40岁组(P=0.028)和>60岁组(P=0.035),差异有统计学意义;农村肾细胞癌患者淋巴结转移(P<0.0001)和远处转移(P=0.002)的比例也显著高于城市。结论不同年龄段肾细胞癌的临床及病理特征存在差异,农村和城市间病理特征没有差异而临床特征有差别;加强肾细胞癌的早期诊断和早期治疗应重视中年人(40~60岁)和农村人群,不可忽视年轻人群(<40岁)、老年人群(>60岁)。 Objective To evaluate the clinicopathologic features of renal cell carcinoma in different ages and circumstance.Methods 256 consecutive cases of renal cell carcinoma(RCC) were reviewed retrospectively.The patients were classified into 3 groups: 40 years group,40-60 years group and 60 years group.The ages,clinical presentations,pathological types,clinical stages and lymph node metastasis were compared.Results The percentage of clear cell RCC increased with the increase of Age.there were significant differences when the component ratios were compared among the 3 groups(P = 0.01) ;The percentage of chromophobe RCC and collecting duct carcinoma diminish with the increasing age,there were significant differences when the component ratios were compared among the 3 groups(P = 0.047) ;there was no difference between city and country.② The percentage of incidental tumor in 40 years group and 60 years group was lower than that in 40-60 years group,there was significant difference between 40 years group and 40-60 years group(P = 0.02) ;The percentage of stage Ⅲ in 40-60 years group was lower than those and in 40 years group(P = 0.04) and 60 years group(P = 0.059),there were significant differences between 40 years group and 40-60 years group;the percentage of stage Ⅰ in rural areas was significantly lower than the group in city,the percentage of stage Ⅲ and the percentage of stage Ⅳ were significantly higher than the proportion of cities.③In 40-60 years group,the proportion of lymph node metastasis occurred in patients with RCC,which was significantly lower than those in 40 years group(P = 0.028) and 60 years group(P = 0.035) ;in rural areas the proportion of lymph node metastasis(P 0.0001) and the proportion of distant metastasis(P = 0.002) occurred in patients with renal RCC,which were significantly higher than those in city.Conclusion There were different clinicopathologic features in different age groups,however,there was no difference and significantly differences in pathological types between rural areas with city.
出处 《实用癌症杂志》 2010年第6期642-645,共4页 The Practical Journal of Cancer
关键词 肾细胞癌 年龄 环境 临床病理学特征 Renal cell carcinoma(RCC) Age Circumstance Clinicopathologic features
  • 相关文献

参考文献12

  • 1Lipworth L,Tarone RE,McLaughlin JK.The epidemiology of renal cell carcinoma[J].J Urol,2006,176((6Pt1):2353.
  • 2Jemal A,Tiwari RC,Murray T,et al.Cancer statistics[J].CA Cancer J Clin,2004,54(1):8.
  • 3李爱军,孙颖浩,杨波,王林辉.450例肾细胞癌的临床回顾分析[J].临床泌尿外科杂志,2006,21(12):907-909. 被引量:11
  • 4马建辉.肾细胞癌诊断治疗指南.见:那彦群,孙光.中国泌尿外科疾病诊断治疗指南[M].北京:人民卫生出版社,2009:1-15.
  • 5Gudbjartsson T,Thoroddsen A,Petursdottir V,et al.Effect of incident detection for survival of patients with renal cell carcinoma:Result of population-based study of 701 patients[J].Urology,2005,66(6):1186.
  • 6Abou El,Fettouh HI,Cherullo EE,et al.Sporadic renal c-ell carcinoma in young adults:presentation,treatment,and outcome[J].Urology,2002(5),60:806.
  • 7Gillett MD,Cheville JC,Karnes RJ,et al.Comparison of presentation and outcome for patients 18 to 40 and 60 to 70 years old with solid renal masses[J].J Urol,2005,173(6):1893.
  • 8Houston Thompson,MD,Maria A,et al.Renal cell carcinoma in young and old patients:Is there a difference?[J].J Urol,2008,180(4):1262.
  • 9Suh JH,Oak T,Ro JY,et al.Clinicopathologic features of renal cell carcinoma in young adults:a comparison study with renal cell carcinoma in older patients[J].Int J Clin Exp Pathol,2009,2(5),489.
  • 10Denzinger S,OttoW,Burger M,et al.Sporadic renal cell carcinoma in young and elderly patients:are there different clinicopathological features and disease specific survival rates?[J].World J Surg Oncol,2007,5(5):16.

二级参考文献17

  • 1Arie B,Jean BD.Renal Tumors.In:Patrick CW,Alan BR,Darracott EV,et al.Campbell' s Urology.7 ed.Beijing:Science Press,2001.2283 -2292.
  • 2潘柏年..肾肿瘤..吴在德,吴肇汉,主编..外科学.第6版..北京:人民卫生出版社,,2003..709-710..
  • 3Tanaka Y,Sasaki M,Kaneuchi M,et al.Estrogen receptor alpha polymorphisms and renal cell carcinoma-a possible risk.Mol Cell Endocrinol,2003,202:109-116.
  • 4Li JJ,Weroha SJ,Davis MF,et al.ER and PR in renomedullary interstitial cells during Syrian hamster estrogen-induced tumorigenesis:evidence for receptor-mediated oncogenesis.Endocrinology,2001,142:4006-4014.
  • 5Wolf DC,Goldsworthy TL,Donner EM,et al.Estrogen treatment enhances hereditary renal tumor development in Eker rats.Carcinogenesis,1998,19:2043 -2047.
  • 6Li JJ,Papa D,Li SA.Ectopic uterine stem cell tumors in the hamster kidney.A unique model for estrogen-induced oncogenesis.Minerva Endocrinol,2003 ,28 :321-328.
  • 7Tsui KH,Shvarts O,Smith RB,et al.Renal cell carcinoma:prognostic significance of incidentally detected tumors.J Urol,2000,163:426-430.
  • 8Luciani LG,Cestari R ,Tallarigo C.Incidental renal cell carcinomaage and stage characterization and clinical implications:study of 1092 patients (1982-1997).Urology ,2000,56:58-62.
  • 9Abou El Fettouh HI,Cherullo EE,El-Jack M,et al.Sporadic renal cell carcinoma in young adults:presentation,treatment,and outcome.Urology,2002,60:806 -810.
  • 10Sanchez-Ortiz RF,Rosser CJ,Madsen LT,et al.Young age is an independent prognostic factor for survival of sporadic renal cell carcinoma.J Urol,2004,171 (6 Pt 1) :2160-2165.

共引文献19

同被引文献17

  • 1Harshman LC,Yu RJ,Allen GI,et al. Surgical outcomes and compli - cations associated with presurglcal tyrosine kinase inhibition for advanced renal cell carcinoma (RCC) [J]. Urol. Oncol, 2013,31: 379-385.18.
  • 2Guo J, Huang YR,Zhang X,et al.Safety and efficacy of everolimus in Chinese patients with metastatic renal cell carcinoma resistant to vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy:an open-label phase lb study[J]. BMC Cancer,2013,13:136.
  • 3National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: kidney cancer.2013.V1.May 12th,2012.
  • 4Procopio G, Bellmunt J, Dutcher J, et al. Sorafenib tolerability in elderly patients with advanced renal cell carcinoma:results from a large pooled analysis[J].Br J Cancer,2013,108:311-318.
  • 5Bergmann L,Goebell PJ,Kube U,et al.Everolimus in metastatic renal cell carcinoma after failure of initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor (VEGFr-TKI) therapy: results of an interim analysis of a non-interventional study[J]. Oncology,2013,36:95-100.
  • 6吴义生,吴长利,陈剑秋.肾癌伴腔静脉癌栓的手术治疗[J].中国肿瘤临床,2010,37(14):817-819. 被引量:1
  • 7王权,周文生.小肾癌的治疗策略[J].中华全科医学,2010,8(12):1590-1592. 被引量:5
  • 8韩精超,纪志刚,李汉忠.肾部分切除术治疗肾肿瘤的安全性及疗效分析[J].中华泌尿外科杂志,2011,32(5):303-306. 被引量:37
  • 9程洋生,周盛川,符建.腹膜后腹腔镜下肾切除术临床应用体会[J].中国伤残医学,2011,19(4):15-16. 被引量:1
  • 10王志向,王林辉.肾癌生长速度的研究进展[J].现代泌尿外科杂志,2012,17(4):425-427. 被引量:3

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部